Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21246245rdf:typepubmed:Citationlld:pubmed
pubmed-article:21246245lifeskim:mentionsumls-concept:C0021311lld:lifeskim
pubmed-article:21246245lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:21246245lifeskim:mentionsumls-concept:C0315222lld:lifeskim
pubmed-article:21246245lifeskim:mentionsumls-concept:C0029443lld:lifeskim
pubmed-article:21246245lifeskim:mentionsumls-concept:C0041041lld:lifeskim
pubmed-article:21246245lifeskim:mentionsumls-concept:C1844376lld:lifeskim
pubmed-article:21246245lifeskim:mentionsumls-concept:C0678226lld:lifeskim
pubmed-article:21246245pubmed:issue2lld:pubmed
pubmed-article:21246245pubmed:dateCreated2011-4-21lld:pubmed
pubmed-article:21246245pubmed:abstractTextEdwardsiella tarda, a catalase-positive bacillus widely distributed throughout nature, is generally susceptible to trimethoprim/sulfamethoxazole. We describe osteomyelitis due to trimethoprim/sulfamethoxazole-resistant E. tarda in a patient with chronic granulomatous disease (CGD). Once E. tarda acquires antibiotic resistance, infected CGD patients may develop severe infections with unforeseeable consequences.lld:pubmed
pubmed-article:21246245pubmed:languageenglld:pubmed
pubmed-article:21246245pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21246245pubmed:citationSubsetIMlld:pubmed
pubmed-article:21246245pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21246245pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21246245pubmed:statusMEDLINElld:pubmed
pubmed-article:21246245pubmed:monthAprlld:pubmed
pubmed-article:21246245pubmed:issn1439-0973lld:pubmed
pubmed-article:21246245pubmed:authorpubmed-author:KawaiTTlld:pubmed
pubmed-article:21246245pubmed:authorpubmed-author:KobayashiSSlld:pubmed
pubmed-article:21246245pubmed:authorpubmed-author:RANDE OEOlld:pubmed
pubmed-article:21246245pubmed:authorpubmed-author:OnoderaMMlld:pubmed
pubmed-article:21246245pubmed:authorpubmed-author:KusakabeHHlld:pubmed
pubmed-article:21246245pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21246245pubmed:volume39lld:pubmed
pubmed-article:21246245pubmed:ownerNLMlld:pubmed
pubmed-article:21246245pubmed:authorsCompleteYlld:pubmed
pubmed-article:21246245pubmed:pagination171-3lld:pubmed
pubmed-article:21246245pubmed:meshHeadingpubmed-meshheading:21246245...lld:pubmed
pubmed-article:21246245pubmed:meshHeadingpubmed-meshheading:21246245...lld:pubmed
pubmed-article:21246245pubmed:meshHeadingpubmed-meshheading:21246245...lld:pubmed
pubmed-article:21246245pubmed:meshHeadingpubmed-meshheading:21246245...lld:pubmed
pubmed-article:21246245pubmed:meshHeadingpubmed-meshheading:21246245...lld:pubmed
pubmed-article:21246245pubmed:meshHeadingpubmed-meshheading:21246245...lld:pubmed
pubmed-article:21246245pubmed:meshHeadingpubmed-meshheading:21246245...lld:pubmed
pubmed-article:21246245pubmed:meshHeadingpubmed-meshheading:21246245...lld:pubmed
pubmed-article:21246245pubmed:meshHeadingpubmed-meshheading:21246245...lld:pubmed
pubmed-article:21246245pubmed:meshHeadingpubmed-meshheading:21246245...lld:pubmed
pubmed-article:21246245pubmed:meshHeadingpubmed-meshheading:21246245...lld:pubmed
pubmed-article:21246245pubmed:meshHeadingpubmed-meshheading:21246245...lld:pubmed
pubmed-article:21246245pubmed:meshHeadingpubmed-meshheading:21246245...lld:pubmed
pubmed-article:21246245pubmed:year2011lld:pubmed
pubmed-article:21246245pubmed:articleTitleOsteomyelitis due to trimethoprim/sulfamethoxazole-resistant Edwardsiella tarda infection in a patient with X-linked chronic granulomatous disease.lld:pubmed
pubmed-article:21246245pubmed:affiliationDepartment of Human Genetics, National Center for Child Health and Development, Tokyo, Japan. kawai-t@ncchd.go.jplld:pubmed
pubmed-article:21246245pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21246245pubmed:publicationTypeCase Reportslld:pubmed